×

Was the EBV mimicry Idea based on Quicksand?

Tweet A couple of years ago we were awakened to the prospect of EBV being the cause of multiple sclerosis, at least part of the causal route. It was based on two papers one that it was shown that people who develop MS were infected…

More Than Just the Sniffles: Navigating Colds and Flu with MS

For the average person, catching a cold is a minor inconvenience—a few days of tissues and cough syrup before bouncing back to work. But for those of us living with multiple sclerosis (MS), the narrative is often drastically different. We … Continue reading → Source:…

ACTRIMS 2026: Fenebrutinib matches Ocrevus in PPMS trial

The investigational BTK inhibitor fenebrutinib was as effective as the approved therapy Ocrevus (ocrelizumab) at reducing the risk of disability progression in people with primary progressive multiple sclerosis (PPMS), meeting the main goal of a Phase 3 trial. According to fenebrutinib’s developer, Genentech, the therapy is…

Antibodies in the brain

Tweet This week I was arguing that PIRA is a terrible concept because a significant element is due to actions outside the CNS…I suggested that most antibody delivered never reach the CNS. To the average of 80Kg volunteers they give 6mg/kg = 480mg (more than…

Remembering February Losses

The month of February may be a shorter month, but it has left a few empty places in my heart. Of course, despite a couple of heartbreaking events that occurred during February, a few great things also happened. It is, as we have always heard, that you cannot have sunshine…

MS: Feeling seen doesn’t always mean feeling heard

Despite this, I often refer to MS as a lonely illness. With a vast array of associated neurological and non-neurological symptoms spread over four different types of MS, it will be exponentially difficult to find someone who has the exact same symptoms with a similarly…